- Home
- CUE vs NMS Comparison
CUE vs NMS Comparison
Compare CUE & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- NMS
- Stock Information
- Founded
- CUE 2014
- NMS 1993
- Country
- CUE United States
- NMS United States
- Employees
- CUE N/A
- NMS N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- CUE Health Care
- NMS Finance
- Exchange
- CUE Nasdaq
- NMS Nasdaq
- Market Cap
- CUE 58.9M
- NMS 68.7M
- IPO Year
- CUE 2018
- NMS N/A
- Fundamental
- Price
- CUE $0.78
- NMS $11.70
- Analyst Decision
- CUE Strong Buy
- NMS
- Analyst Count
- CUE 3
- NMS 0
- Target Price
- CUE $3.00
- NMS N/A
- AVG Volume (30 Days)
- CUE 158.3K
- NMS 12.0K
- Earning Date
- CUE 05-20-2025
- NMS 01-01-0001
- Dividend Yield
- CUE N/A
- NMS 4.11%
- EPS Growth
- CUE N/A
- NMS N/A
- EPS
- CUE N/A
- NMS N/A
- Revenue
- CUE $9,287,000.00
- NMS N/A
- Revenue This Year
- CUE N/A
- NMS N/A
- Revenue Next Year
- CUE $25.99
- NMS N/A
- P/E Ratio
- CUE N/A
- NMS N/A
- Revenue Growth
- CUE 69.16
- NMS N/A
- 52 Week Low
- CUE $0.45
- NMS $9.21
- 52 Week High
- CUE $2.26
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- CUE 46.03
- NMS 47.27
- Support Level
- CUE $0.71
- NMS $11.43
- Resistance Level
- CUE $0.78
- NMS $11.84
- Average True Range (ATR)
- CUE 0.06
- NMS 0.11
- MACD
- CUE 0.01
- NMS 0.02
- Stochastic Oscillator
- CUE 46.11
- NMS 65.85
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.